SI1462107T1 - Postopek za Ĺľensko kontracepcijo in komplet za uporabo pri takem postopku - Google Patents

Postopek za Ĺľensko kontracepcijo in komplet za uporabo pri takem postopku

Info

Publication number
SI1462107T1
SI1462107T1 SI200331473T SI200331473T SI1462107T1 SI 1462107 T1 SI1462107 T1 SI 1462107T1 SI 200331473 T SI200331473 T SI 200331473T SI 200331473 T SI200331473 T SI 200331473T SI 1462107 T1 SI1462107 T1 SI 1462107T1
Authority
SI
Slovenia
Prior art keywords
estradiol
beta
estrogen
amount equivalent
progestogen
Prior art date
Application number
SI200331473T
Other languages
English (en)
Inventor
Bennink Herman Jan Tijmen Coelingh
Monique Visser
Original Assignee
Pantarhei Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32798964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1462107(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv
Publication of SI1462107T1 publication Critical patent/SI1462107T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packaging Of Special Articles (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200331473T 2003-03-28 2003-03-28 Postopek za Ĺľensko kontracepcijo in komplet za uporabo pri takem postopku SI1462107T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03075905A EP1462107B1 (en) 2003-03-28 2003-03-28 Method of female contraception and kit for use in such method

Publications (1)

Publication Number Publication Date
SI1462107T1 true SI1462107T1 (sl) 2009-02-28

Family

ID=32798964

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331473T SI1462107T1 (sl) 2003-03-28 2003-03-28 Postopek za Ĺľensko kontracepcijo in komplet za uporabo pri takem postopku

Country Status (7)

Country Link
EP (1) EP1462107B1 (sl)
AT (1) ATE409041T1 (sl)
DE (1) DE60323725D1 (sl)
DK (1) DK1462107T3 (sl)
ES (1) ES2314156T3 (sl)
PT (1) PT1462107E (sl)
SI (1) SI1462107T1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
WO2006036055A2 (en) * 2004-09-27 2006-04-06 Pantarhei Bioscience B. V. Method of female contraception and kit for use in such method
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
SE9403389D0 (sv) * 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6265393B1 (en) * 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
EP1390038A2 (en) * 2001-05-16 2004-02-25 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
US20040198707A1 (en) * 2001-05-23 2004-10-07 Agatha Antonia Magdalena Van Beek Means and method for hormonal contraception
ATE254465T1 (de) * 2001-05-23 2003-12-15 Pantarhei Bioscience Bv Zubereitungen für die hormonale kontrazeption
WO2003041719A1 (en) * 2001-11-15 2003-05-22 Pantarhei Bioscience B.V. Method of contraception in mammalian females and pharmaceutical kit for use in such method

Also Published As

Publication number Publication date
EP1462107B1 (en) 2008-09-24
ES2314156T3 (es) 2009-03-16
ATE409041T1 (de) 2008-10-15
EP1462107A1 (en) 2004-09-29
DK1462107T3 (da) 2008-11-03
DE60323725D1 (de) 2008-11-06
PT1462107E (pt) 2009-01-02

Similar Documents

Publication Publication Date Title
NZ591627A (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
GEP20022784B (en) Celecoxib Composition
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
MX9804395A (es) Proceso y equipo anticonceptivos para mamiferos hembra, que comprenden una combinacion de gestageno y estrogeno.
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
DE60020551D1 (de) Orale formulierung zur verabreichung in den ileum enthaltend einen hemmstoff des ileum-gallensäuretransports
PL326196A1 (en) Bioadhesive solid administration form
HUP0402142A2 (hu) Kombinációs ösztrogén-gestagen készítmény és alkalmazása
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
CA2448278A1 (en) Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception
AP2003002763A0 (en) Controlled release formulations for oral administration
NZ505648A (en) Hexadecylphosphocholine (HPC) and a flow controlling agent and/or a lubricant and a filler in a daily dosage of 10-250 mg
SI1462107T1 (sl) Postopek za Ĺľensko kontracepcijo in komplet za uporabo pri takem postopku
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
UA81387C2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
RU2225714C2 (ru) Новый набор противозачаточных средств
MX2007009061A (es) Preparacion farmaceutica para la anticoncepcion oral.
RU2000115313A (ru) Схемы приема гестаген-анти-гестагена
EP3747443A3 (en) Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
Blaney OCs provide emergency contraception option
HUP0203655A2 (hu) Telítetlen 14,15-ciklopropano-androsztánok, előállításukat szolgáló eljárás és ezen vegyületeket tartalmazó gyógyszerészeti készítmények
AR033260A1 (es) Nueva composicion hormonal y su utilizacion
BG104673A (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
Lee et al. Efficacy of Simplified Protocols in IVF-ET with Highly Purified FSH [FSH-HP] for Ovulation Induction
WO2006036055A3 (en) Method of female contraception and kit for use in such method